Clinical trial
Safety and Efficacy of Ademetionine in Patients With Obstructive Hypertrophic Cardiomyopathy: A Multicenter, Double-Blind, Randomized Controlled, Phase 2 Study
NCT07367724 is registered in ClinicalTrials.gov with China National Center for Cardiovascular Diseases as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of Ademetionine in Patients With Obstructive Hypertrophic Cardiomyopathy: A Multicenter, Double-Blind, Randomized Controlled, Phase 2 Study
- Lead sponsor
- China National Center for Cardiovascular Diseases
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- January 1, 2026
- Completion date
- December 31, 2027
- Enrollment
- 44 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
obstructive hypertrophic cardiomyopathy (ohcm)